¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Pittsburgh pneumonia agent"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® pneumonia ÇÑ±Û Æó·Å
¼³¸í   
  ÆóÀÇ ¿°ÁõÀ¸·Î ÆóÆ÷ ³»¿¡ °ø±â ´ë½Å ¿°Áõ ¼¼Æ÷³ª »ïÃâ¾×À¸·Î °¡µæ Â÷ È£Èí°ï¶õÀ» ¾ß±âÇϸç, ¹ß¿­ µîÀÇ Àü½Å Áõ»óÀ» µ¿¹ÝÇÑ´Ù. À§Ä¡, ¿øÀαՠµî¿¡ µû¶ó ±¸ºÐÇÑ´Ù.
  
  ¿¹¸¦ µé¾î, ´ë¿±¼º Æó·Å(lobar pneumonia)¶õ Æó·Å ±¸±Õ¿¡ ÀÇÇÑ ±Þ¼º Æä·ÅÀ¸·Î ÇÑ °³ ¶Ç´Â ¿©·¯ °³ÀÇ Æó¿±À» µû¶ó »ý±â´Â ±¤¹üÀ§ÇÑ »ïÃ⼺ °æÈ­°¡ Æ¯Â¡ÀΠº´À» ÁöĪÇÑ´Ù. À̰ÍÀº Æó·ÅÀÇ ¹ß»ýºÎÀ§¿¡ µû¶ó ºÎ¸£´Â ¸»ÀÌ´Ù. ±×¸®°í ¹ÙÀÌ·¯½ºÆó·Å(viral pneumonia)¶õ ¹ÙÀÌ·¯½º¿¡ ÀÇÇØ ¹ß»ýÇϴ ¸ðµç Æó·ÅÀ» ¸»Çϴµ¥, À̰ÍÀº ¿øÀαտ¡ µû¶ó ÁöĪÇÑ ¸»ÀÌ´Ù.
¿µ¹® aspiration pneumonia ÇÑ±Û ÈíÀÎÆó·Å
¼³¸í   
  À½½Ä¹°ÀÇ Â±â°°Àº À̹°ÀÌ ±âµµ¿¡ µé¾î°¡ ÀÌÂ÷ÀûÀ¸·Î »ý±â´Â Æó·Å. À½½Ä¹°À̳ª ÀÔ¾ÈÀÇ ¹Ì»ý¹°ÀÌ ½Äµµ·Î ³Ñ¾î°¡Áö ¾Ê°í ±âµµ·Î À߸ø ÈíÀεǾ߱âµÇ´Â Æó·ÅÀ» ¸»ÇÑ´Ù. ÈíÀΠ¹°ÁúÀǠƯ¼º¿¡ µû¶ó¼­ ¼¼ °¡Áö ÁõÈıºÀ» Æ÷ÇÔÇÑ´Ù. ¨ç È­ÇÐÀû Æó·ÅÀº Á÷Á¢ÀûÀ¸·Î Æó¿¡ À¯ÇØÇÑ ¹°ÁúÀ» ÈíÀÎÇßÀ» ¶§ ÀϾ¸ç, ±Þ¼º È£Èí°ï¶õ, ºü¸¥ È£Èí, ºü¸¥¸ÆÀÌ ³ªÅ¸³ª°í µ¿¹ÝµÇ´Â Áõ»óÀº ÁַΠû»öÁõ, ±â°üÁö °æ·Ã, ¿­ µîÀÌ´Ù. ¨è Çϱ⵵ÀÇ ¼¼±Õ¼º °¨¿°ÀÌ ÈíÀμº Æó·ÅÀÇ °¡Àå ÈçÇÑ ÇüÅ·Î, ±âħ, ¹ß¿­, °í¸§°¡·¡ Áõ»óÀ» ³ªÅ¸³½´Ù. ¨é Çϱ⵵ÀÇ ±â°èÀû Æó¼â´Â Æ¯º°ÇÑ ¹°Áú, Æ¯È÷ ¶¥Äá, ÀÛÀº °í±âµ¢¾î¸®¿¡ ÀÇÇØ ÈíÀεǾúÀ» ¶§ ÀϾ¸ç, ÈíÀΠ¹°Áú°ú ±âµµÀÇ Á÷°æ¿¡ µû¶ó Áõ»óÀº ´Ù¸£´Ù. ±â°ü¿¡¼­ ¸·È÷¸é Á¾Á¾ È£Èí°ï¶õ°ú ÇÔ²² »ç¸Á¿¡ À̸£±âµµ Çϸç, Çϱ⵵ ¾Æ·¡ ºÎºÐ¿¡¼­ ÈíÀÎÀÌ ÀϾ¸é ¸¸¼º ±âħÀÌ ¹ß»ýÇÑ´Ù.
¿µ¹® cardiotonic, cardiotonic agent ÇÑ±Û °­½ÉÁ¦
¼³¸í   
  ½ÉÀåÀÇ ¼öÃà·ÂÀ» Áõ°¨½Ã۴ ¾à¹°À» ¸»ÇÑ´Ù. ±âº»ÀûÀ¸·Î ½É±Ù¼öÃà·ÂÀ» Áõ°­½ÃÄÑ ½ÉÀå¹ÚÃâ·®À» Áõ°¡½Ã۴ ¾à¹°ÀÌ´Ù. °­½É¹è´çü, Æ÷½ºÆ÷µð¿¡½ºÆ®¶ó¾ÆÁ¦ ¾ïÁ¦Á¦, ¾Æµå·¹³¯¸° ¥â¼ö¿ëüÀÛ¿ëÁ¦, Ç÷°üÈ®ÀåÁ¦ µîÀÌ ÀÖ´Ù. ´ëÇ¥ÀûÀΠ¿¹·Î¼­´Â µð°î½Å(digoxine) µîÀÇ µðÁöÅ»¸®½º(digitalis)°¡ ÀÖ´Ù.
¿µ¹® alkylating agent ÇÑ±Û ¾Ëųȭ¾à¹°
¼³¸í   
  Ç×¾ÏÁ¦ÀÇ ÀÏÁ¾. ÀÌ»óÀûÀΠÇ×¾ÏÁ¦´Â Á¤»óÀûÀΠ¼¼Æ÷¿¡´Â Çظ¦ ÁÖÁö ¾Ê°í ´ÜÁö ¾Ï¼¼Æ÷¿¡¸¸ Ä¡¸íÀûÀΠȿ°ú¸¦ ³ªÅ¸³»¾ß ÇÑ´Ù. ÀÌ·¸°Ô ÇÏ·Á¸é ¾Ï¼¼Æ÷¸¸ÀǠƯÀÌÇѠƯ¼ºÀ» ÀÌÇØÇÏ°í ±×°÷¿¡¸¸ ÀÛ¿ëÇϴ ¾à¹°À» °³¹ßÇØ¾ß ÇÑ´Ù. ÇöÀç ´ëºÎºÐÀÇ Ç×¾ÏÁ¦´Â ¾Ï¼¼Æ÷°¡ Á¤»ó ¼¼Æ÷¿¡ ºñÇÏ¿© ¿ùµîÈ÷ Áõ½ÄÀ» »¡¸®ÇѴٴ Ư¼ºÀ» ÀÌ¿ëÇϰí ÀÖ´Ù. Áõ½ÄÀÌ ºü¸£´Ù´Â °ÍÀº ´Ù½Ã ¸»Çϸé À¯Àü Á¤º¸¸¦ °¡Áö°í Àִ DNAÀÇ º¹Á¦°¡ ºü¸£´Ù´Â °ÍÀ» ÀǹÌÇÑ´Ù. ¸¸¾à DNAÀÇ º¹Á¦¸¦ ¹æÇØÇÑ´Ù¸é Áõ½ÄÀÌ ¾ÆÁÖ ºü¸¥ ¾Ï¼¼Æ÷¿¡°Ô´Â Ä¡¸íÀûÀÌÁö¸¸ ¿µ¿øÈ÷ Áõ½ÄÀ» ÇÏÁö ¾Ê´Â DNAÀÇ º¹Á¦°¡ °ÅÀÇ ÇÊ¿ä¾ø´Â)½Å°æ¼¼Æ÷³ª Áõ½ÄÀÌ ¾Ï¼¼Æ÷¿¡ ºñÇØ¼­ ¾ÆÁÖ ´À¸° Á¤»ó¼¼Æ÷¿¡´Â °ÅÀÇ ¿µÇâÀ» ÁÖÁö ¸øÇÑ´Ù. ÇÏÁö¸¸ ½Åü¿¡¼­µµ Áõ½ÄÀÌ ¾Ï¼¼Æ÷¿Í ºñ½ÁÇÑ ¼öÁØÀ¸·Î ÀϾ´Â Á¤»óÀûÀΠ¼¼Æ÷°¡ Àִµ¥ ±×°ÍÀº ¸Ó¸®Ä«¶ôÀ» ¸¸µå´Â ¸ð³¶¼¼Æ÷¿Í ¼ÒÈ­°üÀÇ Á¡¸·À» ÀÌ·ç´Â ¼¼Æ÷¿Í Ç÷¾×ÀÇ ¼¼Æ÷¸¦ ¸¸µå´Â °ñ¼ö ¼¼Æ÷ÀÌ´Ù. ±×·¯¹Ç·Î Ç×¾ÏÁ¦¸¦ »ç¿ëÇÒ °æ¿ì ¾Ï¼¼Æ÷¿Í ¸¶Âù°¡Áö·Î À̵頼¼Æ÷µµ ÇÔ²² Ä¡¸íÀûÀΠ¿µÇâÀ» ÀÔÀ» °ÍÀº ´ç¿¬ÇÏ´Ù(±×·¡¼­ Ç×¾ÏÁ¦ Ä¡·á½Ã¿£ ¸Ó¸®°¡ ºüÁö°í ¼ÒÈ­ºÒ·®ÀÌ Àß ¿Â´Ù). ¾ËĮȭ¾à¹°ÀÇ °æ¿ì¿¡´Â DNA¿Í Á÷Á¢ °áÇÕÀ» ÇÏ¿© DNAÀÇ º¹Á¦¸¦ ¾ïÁ¦ÇÔÀ¸·Î½á Ç×¾ÏÁ¦ÀÇ ¿ªÇÒÀ» ¼öÇàÇÑ´Ù.
¿µ¹® anti-inflammatory agent ÇÑ±Û Ç׿°ÁõÁ¦, ¼Ò¿°Á¦, ¿°Áõ¾à
¼³¸í   
  ±¹¼Ò¿¡ ÀÛ¿ëÇÏ¿© ¿°ÁõÀ» Ä¡·áÇÏ°í ¹æÁöÇϴ ¾à. ¿°ÁõÀ» °¡¶ó¾ÉÈ÷´Â ¾àÀ» ¸»ÇÑ´Ù. Á¶Á÷À» ±äÃà-Ä¡¹ÐÇϰԠÇÏ¿© Àå¾×°ú Á¡¾×ÀÇ ºÐºñ¸¦ ÁÙÀ̰í, Ç¥¸é¿¡ Àִ ÀÛÀº Ç÷°ü¿¡ ºóÇ÷À» ÀÏÀ¸ÄÑ ÃæÇ÷µÇ´Â °ÍÀ» ¹æÁöÇÔÀ¸·Î½á ¿°ÁõÀû º´º¯À» Á¦°ÅÇÏ¿© ¸ðµç Áõ¼¼¸¦ ¾ø¾Ø´Ù. ´ëºÎºÐÀÇ ¼ö·ÅÁ¦-¿ÏÈ­Á¦-Áø¾çÁ¦°¡ ÀÌ¿¡ ¼ÓÇÑ´Ù. Áß¿äÇÑ ¼ººÐÀ¸·Î´Â ¾Ë·ç¹Ì´½-ºñ½º¹«Æ®-¾Æ¿¬-³³È­ÇÕ¹°(º´¹Ý-Æä¸£¸¶Åç-¾Æ¿¬È­-¿¬´ç µî) µîÀÌ ÀÖ´Ù. ÀÛ¿ë¿¡ µû¶ó Ç׿°ÁõÁøÅëÁ¦¿Í Ç׿°ÁõÈ¿¼ÒÁ¦·Î ³ª´¶´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aspiration pneumonia
    ÈíÀÎÆó·Å
  • atypical pneumonia
    ºñÁ¤ÇüÆó·Å
  • acute pneumonia
    ±Þ¼ºÆó·Å
  • bronchiolitis obliterans-organizing pneumonia
    Æó¼â¼¼±â°üÁö±âÁúÈ­Æó·Å
  • croupous pneumonia
    ¿±Æó·Å
  • desquamative interstitial pneumonia
    ¹Ú¸®»çÀÌÁúÆó·Å, ¹Ú¸®°£ÁúÆó·Å
  • eosinophilic pneumonia
    È£»ê±¸Æó·Å
  • ephemeral pneumonia
    ÀϽüºÆó·Å
  • giant cell pneumonia
    °Å´ë¼¼Æ÷Æó·Å
  • hypostatic pneumonia
    ħ°­¼ºÆó·Å
  • indurative pneumonia
    °æÈ­Æó·Å
  • inhalation pneumonia
    ÈíÀÔÆó·Å
  • interstitial plasma cell pneumonia
    »çÀÌÁúÇüÁú¼¼Æ÷Æó·Å, ÆóÆ÷ÀÚÃæÁõ
  • interstitial pneumonia
    °£ÁúÆó·Å, »çÀÌÁúÆó·Å
  • lipid pneumonia
    ÁöÁúÆó·Å
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pneumonia
    Æó·Å, ÇãÆÄ¿°
  • acute pneumonia
    ±Þ¼ºÆó·Å
  • aspiration pneumonia
    ÈíÀÎÆó·Å
  • atypical pneumonia
    ºñÁ¤ÇüÆó·Å
  • giant cell pneumonia
    °Å´ë¼¼Æ÷Æó·Å
  • interstitial pneumonia
    °£ÁúÆó·Å, »çÀÌÁúÆó·Å
  • nosocomial pneumonia
    º´¿ø³»Æó·Å
  • Streptococcus pneumonia
    Æó·Å»ç½½¾Ë±Õ, Æó·Å¿¬¼â±¸±Õ
  • agent
    1. ¾à¹°, ¾àÁ¦, 2. ¹°Áú, 3. ÀÎÀÚ
  • alkylating agent
    ¾Ëųȭ¾à¹°, ¾ËųȭÁ¦
  • anti-inflammatory agent
    Ç׿°ÁõÁ¦, ¼Ò¿°Á¦, ¿°Áõ¾à
  • antiasthmatic agent
    Ç×õ½ÄÁ¦
  • antifungal agent
    Ç×Áø±ÕÁ¦
  • antimetabolic agent
    Ç×´ë»ç¹°Áú
  • antitumor agent
    Ç×¾ÏÁ¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aspiration pneumonia
    ÈíÀÎÆó·Å
  • bronchiolitis obliterans-organizing pneumonia
    Æó¼â¼¼±â°üÁö±âÁúÈ­Æó·Å
  • croupous pneumonia
    (¢¡lobar pneumonia) ¿±Æó·Å
  • ephemeral pneumonia
    ÀϽüºÆó·Å
  • giant cell pneumonia
    °Å´ë¼¼Æ÷Æó·Å
  • hypostatic pneumonia
    ħ°­¼ºÆó·Å
  • indurative pneumonia
    °æÈ­Æó·Å
  • inhalation pneumonia
    ÈíÀÔÆó·Å
  • interstitial pneumonia
    °£ÁúÆó·Å, »çÀÌÁúÆó·Å
  • lipid pneumonia
    ÁöÁúÆó·Å
  • lobar pneumonia
    ¿±Æó·Å
  • lobular pneumonia
    (¢¡bronchopneumonia) ±â°üÁöÆó·Å
  • migratory pneumonia
    À¯ÁÖÆó·Å
  • pneumonia
    Æó·Å, ÇãÆÄ¿°
  • rheumatic pneumonia
    ·ù¸¶Æ¼½ºÆó·Å
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Pittsburgh pneumonia [agent]
    ÇÇÃ÷¹ö±×Æó·Å(¿øÀÎü), ·¹Áö¿À³Ú¶óÁõ(¿øÀÎü)
  • Eatons agent pneumonia
    ÀÌÆ°º´¿øÃ¼Æó·Å.
  • Loeffler s pneumonia
    ·ÚÇ÷¯Æó·Å.
  • Pneumocystis carinii pneumonia
    ÁÖÆóÆ÷ÀÚÃþ Æó·Å.
  • acute pneumonia
    ±Þ¼ºÆó·Å (~øËæú)
  • acute pneumonia
    ±Þ¼º Æó·Å(¡­øËæú).
  • acute pneumonia
    ±Þ¼º Æó·Å(?̰Ëç).
  • acute tuberculous pneumonia
    ±Þ¼º °áÇÙ¼º Æó·Å(¡­Ì¿ú·àõøËæú).
  • ambulatory pneumonia
    À¯ÁÖ¼º Æó·Å(ë´ñËàõøËæú).
  • apical pneumonia
    Æó÷ºÎÆó·Å(¡­øËæú).
  • ascariasis pneumonia
    È¸Ãæ¼º Æó·Å.
  • giant cell pneumonia
    °Å¼¼Æ÷Æó·Å.
  • hemolytic streptococcal pneumonia
    ¿ëÇ÷¼º ¿¬¼â±¸±ÕÆó·Å.
  • hypersensitivity pneumonia
    °ú¹Î¼º Æó·Å.
  • hypostatic pneumonia
    ħ°­¼º Æó·Å.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acute pneumonia
    ±Þ¼º Æó·Å(?̰Ëç).
  • acute pneumonia
    ±Þ¼ºÆó·Å (~øËæú)
  • acute pneumonia
    ±Þ¼º Æó·Å(¡­øËæú).
  • acute tuberculous pneumonia
    ±Þ¼º °áÇÙ¼º Æó·Å(¡­Ì¿ú·àõøËæú).
  • alcoholic pneumonia
    À½ÁÖ°¡ Æó·Å(ëæñÐÊ« øËæú).
  • ambulatory pneumonia
    À¯ÁÖ¼º Æó·Å(ë´ñËàõøËæú).
  • apical pneumonia
    Æó÷ºÎÆó·Å(¡­øËæú).
  • ascariasis pneumonia
    È¸Ãæ¼º Æó·Å.
  • aspiration pneumonia
    ÈíÀμº Æó·Å, ¼º(¿¬)ÇÏ(¼º) Æó·Å.
  • asthenia pneumonia
    ¹«·Â¼º Æó·Å(¡­øËæú).
  • atypical pneumonia
    ÀÌÇü<ºñÁ¤Çü>Æó·Å (¡­øËæú).
  • bacterial pneumonia
    ¼¼±Õ¼º Æó·Å(¡­øËæú).
  • bronchial pneumonia
    ±â°üÁöÆó·Å(¡­øËæú).
  • bronchiolitis obliterans-organizing pneumonia(boop)
    Æó¼â¼º ¼¼±â°üÁö-±âÁúÈ­Æó·Å(ºÎÇÁ Æó·Å)(øÍáðàõ¡­øËæú)
  • cold agglutinin positive pneumonia
    ÇÑ·©ÀÀÁý¼Ò ¾ç¼ºÆó·Å.
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antiprotozoal agent
    Ç׿øÃæÁ¦
  • interstitial plasma cell pneumonia
    °£Áú¼ºÇüÁú¼¼Æ÷Æó¿°
  • Pneumocystis carinii pneumonia
    ÆóÆ÷ÀÚÃæÆó¿°
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Agent Orange
    ¿¡ÀÌÁ¨Æ® ¿À·»Áö
  • antibacterial agent
    Ç×±ÕÁ¦(ù÷жð¥)
  • antichaotropic agent
    Ç×(ù÷)ÄÉÀÌ¿À¼º(àõ) Á¦(ð¥)
  • antidotal agent
    ÇØµ¶Á¦Á¦(ú°Ô¸ð²ð¥)
  • antimitotic agent
    Ç×À¯»çºÐ¿­Á¦(ù÷êóÞêÝÂÖ®ð¥)
  • antithyroid agent
    Ç×°©»ó¼±Á¦(ù÷Ë£ßÒàÍð¥)
  • antiviral agent
    Ç×(ù÷) ¹ÙÀÌ·¯½ºÁ¦(ð¥)
  • bactericidal agent
    »ì±ÕÁ¦(߯жð¥)
  • bacteriostatic agent
    Á¤±ÕÁ¦(ð¡Ð¶ð¤)
  • chaotropic agent
    ¹«Áú¼­À¯¹ßÁ¦(Ùíòñßíë¯Û¡ð¥)
  • chelating agent
    ų·¹ÀÌÆ®Á¦(ð¥)
  • chemotherapeutic agent
    È­Çпä¹ýÁ¦(ûùùÊÖûÛöð¥)
  • cytostatic agent
    ¼¼Æ÷Áõ½Ä¾ïÁ¦Á¦(á¬øàñòãÖåäð¤ð¥)
  • denaturing agent
    º¯¼ºÁ¦(ܨàõð¥)
  • eluting agent
    ¿ë¸®Á¦(éÁ×îð¥)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aspiration pneumonia
    ÈíÀμºÆó·Å
  • diffuse interstitial pneumonia
    ¹Ì¸¸¼º°£Áú¼ºÆó·Å
  • eosinophilic pneumonia
    È£»ê±¸¼ºÆó·Å
  • interstitial pneumonia
    °£Áú¼ºÆó·Å
  • lipoid pneumonia
    ¸®Æ÷À̵åÆó·Å, À¯ÁöÁúÆó·Å
  • lobar pneumonia
    ´ë¿±¼ºÆó·Å
  • migratory pneumonia
    À¯ÁÖÆó·Å
  • mycotic pneumonia
    Áø±Õ¼ºÆó·Å
  • oil pneumonia
    À¯¼ºÆó·Å
  • organizing pneumonia
    ±âÁúÈ­ÇÏ´Â Æó·Å
  • plasma cell pneumonia
    ÇüÁú¼¼Æ÷¼ºÆó·Å
  • pneumococcal pneumonia
    Æó·Å±¸±Õ(¼º)Æó·Å
  • pneumonia
    Æó·Å
  • rheumatic pneumonia
    ·ù¸¶Æ¼½º¼ºÆó·Å
  • round pneumonia
    ¿øÇüÆó·Å
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PPA palpation, percussion, auscultation; pepsin A; phenylpropanolamine; phenylpyruvic acid; Pittsburgh p...
AP accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p...
SMCA smooth muscle contracting agent; suckling mouse cataract agent
AT-P antitrypsin-Pittsburgh
rAT-P recombinant antitrypsin Pittsburgh
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
a Agent
CAA Chicken anaemia agent
FWA fluorescent whitening agent
NMBA Neuromuscular blocking agent
SMA Snow Mountain Agent
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute pneumonia
    ±Þ¼º Æó·Å
    ¹ÙÀÌ·¯½º, ¼¼±Õ µî¿¡ ÀÇÇØ¼­ »ý±â´Â Æó ½ÇÁúÀÇ ±Þ¼º ¿°ÁõÀÌ°í º´º¯ÀÇ Áß½ÉÀº ÆóÆ÷ »óÇÇ, ¼¼Æ÷ °­¿¡ ÀÖÀ¸¸ç, ÆóÆ÷³»¿¡ ´Ù·®ÀÇ Ä§Ãâ¹°ÀÌ Ãæ¸¸ÇØ X-¼± Çʸ§ »ó¿¡¼­´Â ±â°üÁö °­À» Á¦¿ÜÇÏ°í ±ÕµîÇÑ ±×¸²ÀÚ·Î µÚµ¤ÀδÙ. Àü¿¡´Â °¨¿° Áúȯ Áß »óÀ§¸¦ Â÷ÁöÇϰí ÀÖ¾ú´Âµ¥ Ç×»ý ¹°ÁúÀÇ µîÀåÀ¸·Î °Ý°¨Çß´Ù. ÃÖ±Ù¿¡´Â ¿ø³»°¨¿°¿¡ µû¸¥ ³­Ä¡ÀÇ ±×¶÷ À½¼º±Õ °¨¿°ÀÌ Áõ°¡ Ãß¼¼¿¡ ÀÖ´Ù.
  • acute tuberculous pneumonia
    ±Þ¼º °áÇÙ¼º Æó·Å
    °áÇÙÀÌ °¨¿°µÇ¾î º¸Åë ¸¸¼º À°¾ÆÁ¾¼º ¿°ÁõÀ» ¾ß±âÇÏ´Â ÀϹÝÀûÀÎ °æ¿ì¿Í ´Þ¸® ±Þ¼º Æó·Å°ú °°ÀÌ ±Þ¼º »ïÃ⼺ ¿°ÁõÀ¸·Î ³ªÅ¸³ª´Â °æ¿ì·Î¼­ ÀúÇ×·ÂÀÌ ¾àÇÑ »ç¶÷¿¡°Ô º¼ ¼ö ÀÖ´Ù.
  • aspiration pneumonia
    ÈíÀμº Æó·Å, ¼ºÇÏ Æó·Å, ¼º¿¬ÇÏ Æó·Å, ¿¬Çϼº Æó·Å, ¼º¿¬Çϼº Æó·Å, ÈíÀÔ¼º Æó¿°
  • bacterial pneumonia
    ¼¼±Õ¼º Æó·Å
    ¼¼±Õ¿¡ ÀÇÇÑ °æÈ­¸¦ µ¿¹ÝÇÏ´Â ÆóÀÇ ¿°Áõ.
  • caseous pneumonia
    °Ç¶ô¼º Æó·Å
    ÆóÀÇ °Ç¶ô¼º º¯È­¸¦ ¼ö¹ÝÇÏ´Â °áÇÙ¼º Æó·Å. »ïÃ⼺ º¯È­°¡ ½ÉÇÑ »óÅ¿¡¼­ ÀϺΰ¡ °Ç¶ô º¯¼ºÀ» ÇÑ ¿°Áõ º´¼Ò·Î µÇ¾î ÀÖ´Ù. Áõ½Ä¼º °áÇÙ°ú ´Þ¶ó Àå¾×, ¼¶À¯¼Ò, ¹éÇ÷±¸, ´ë´ÜÇÙ±¸ µîÀÇ »ïÃâÀÌ ½ÉÇϰí, Æó¿± Àüü°¡ ±¤¹üÀ§ÇÏ°Ô Ä§½ÄµÉ À§ÇèÀÌ ¸¹´Ù. °áÇÙ±Õ¿¡ ´ëÇÑ ¾Ë·¹¸£±â°¡ °ü°èµÈ °ÍÀ¸·Î »ý°¢µÇ°í ÀÖ´Ù.
  • eosinophilic pneumonia
    È£»ê±¸¼º Æó·Å
  • influenzal viral pneumonia
    ÀÎÇ÷翣ÀÚ Æó·Å
    ÀÎÇ÷翣ÀÚ¿¡ °É·Á ÀúÇ×·ÂÀÌ ÀúÇϵǾúÀ» ¶§ ±âµµ¿¡ ÀÖ´ø ¼¼±ÕÀÌ Áõ½ÄµÇ¾î ÀϾ´Â Æó·Å. ÀÌ¿Í °°ÀÌ 2Â÷ °¨¿°À» ÀÏÀ¸Å°´Â ¼¼±ÕÀº Æ÷µµ ±¸±Õ , Æó·Å ±¸±Õ , ¿¬¼â ±¸±Õ , ÀÎÇ÷翣ÀÚ ±Õ , Æó·Å °£±Õ µîÀÌ´Ù. º»ÁõÀÇ ÇÕº´·üÀº À¯Çà¿¡ µû¶ó Å« Â÷°¡ ÀÖÀ¸¸ç ¿¬·ÉÀûÀ¸·Î´Â ³ëÀÎÀÇ °æ¿ì¿¡ ³ô´Ù. Áõ¼¼´Â ÀÎÇ÷翣ÀÚÀÇ °í¿­ÀÌ 2¡­3ÀÏÀÌ µÇ¾îµµ ³»¸®Áö ¾Ê°í, ¶Ç´Â ÀÏ´Ü ³»·È´ø ¿­ÀÌ ´Ù½Ã »ó½ÂÇϸ鼭 È£Èí °ï¶õµµ ´õ¿í ½ÉÇØÁø´Ù. ÀÔ¼úÀ̳ª ¼Õ³¡Àº Â÷°¡¿öÁö°í ûÀÚ»öÀ» ¶í´Ù. ±âħ°ú ´ãµµ ¸¹À¸¸ç, ÈäºÎÀÇ Ã»Áø , ŸÁøÀ̳ª X¼± °Ë»ç¿¡¼­ Æó·ÅÀÇ ¼Ò°ßÀÌ Áõ¸íµÈ´Ù. Ä¡·á´Â 2Â÷ °¨¿°±Õ¿¡ ÀûÀÀµÇ´Â Ç×»ý ¹°ÁúÀ» ¾²´Â ¿Ü¿¡ ÀÏ¹Ý Æó·ÅÀÇ Ä¡·á¿¡ ÁØÇÑ´Ù. ³ëÀÎÀÇ °æ¿ì´Â »ç¸Á·üÀÌ ³ôÀ¸¸ç, ¶ÇÇÑ ÀÎÇ÷翣ÀÚ·Î »ç¸ÁÇÏ´Â »ç¶÷ÀÇ ¾à 80 %´Â Æó·ÅÀÇ ÇÕº´ ¶§¹®ÀÌ´Ù.
  • interstitial pneumonia
    °£Áú¼º Æó·Å
  • migratory pneumonia
    À¯ÁÖ Æó·Å
  • mycotic pneumonia
    Áø±Õ¼º Æó·Å.
  • plasma cell pneumonia
    ÇüÁú ¼¼Æ÷¼º Æó·Å
  • pneumonia
    Æó·Å
    1. ÆóÀÇ ¿°Áõ. ÇÕº´ÁõÀ» °¡Áø ÆóÀÇ ¿°Áõ. 2. Æó¿¡ »ý±â´Â ¿°Áõ. º´¸®ÇغÎÇÐÀûÀ¸·Î ÆóÀÇ ´ë¿± ÀüºÎ¿¡ ¿°ÁõÀÌ ÆÛÁø ´ë¿±¼º Æó·Å°ú, ¼Ò¿± ´ÜÀ§¿¡ ÇÑÁ¤µÈ ¼Ò¿±¼ºÆó·ÅÀ¸·Î ³ª´µ¸ç, º´¿øÃ¼¿¡ µû¶ó¼­µµ ¼¼±Õ¼º Æó·Å°ú ¹ÙÀÌ·¯½º¼º Æó·Å, ¾Ë·¹¸£±â¼º Æó·Å µîÀ¸·Î ³ª´¶´Ù. ¡¼´ë¿±¼º Æó·Å¡½ Å©·çÇÁ¼º Æó·ÅÀ̶ó°íµµ Çϸç, ¿øÀÎÀº ´ëºÎºÐÀÌ Æó·Å ±¸±ÕÀÌ´Ù. ¶§·Î´Â Æó·Å °£±Õ, Æ÷µµ»ó ±¸±Õ, ¿¬¼â ±¸±Õ¿¡ ÀÇÇÏ´Â °Íµµ ÀÖ´Ù. Áõ¼¼´Â ¿ÀÇÑ, ÀüÀ²À» ¼ö¹ÝÇÑ ¹ß¿­ ¿Ü¿¡ ±âħ, ÈäÅë, ³ì»ö °¡·¡, È£Èí °ï¶õ, Ä¡¾Æ³ëÁ¦ µîÀ̸ç, ûÁøÇϸé È¯ÃøÀÇ Æó¾ß´Â È£ÈíÀ½ÀÌ ¾àÇϰí ÀÛÀº ¼öÆ÷À½, ±â°üÁöÀ½ µîÀÌ µé¸°´Ù. X¼± »çÁøÀ¸·Î´Â ÀÌȯµÈ Æó¿±¿¡ ÀÏÄ¡µÈ °æ°è°¡ ¶Ñ·ÇÇÑ À½¿µÀ» ÀÎÁ¤ÇÒ ¼ö ÀÖ´Ù. Ä¡·á´Â Ç×»ý ¹°Áú, ƯÈ÷ ¿øÀÎ ±Õ¿¡ ´ëÇØ °¡Àå À¯È¿ÇÑ °ÍÀ» »ç¿ëÇÑ´Ù. È£Èí °ï¶õÀÌ ½ÉÇÏ¸é »ê¼Ò ÈíÀÔ, ½ÉÀåÀÌ ¼è¾àÇÏ¸é °­½ÉÁ¦¸¦ »ç¿ëÇÏ°í ´ëÁßÀûÀ¸·Î ÁøÅëÁ¦, ÁøÇØÁ¦, ÇØ¿­Á¦¸¦ »ç¿ëÇÑ´Ù. ¡¼±â°üÁö Æó·Å¡½ ±â°üÁöÀÇ ¿°ÁõÀÌ ³»ºÎ±îÁö ÆÛÁ®Æó Á¶Á÷¿¡ À̸£·¯ ÀϾ´Â °ÍÀ¸·Î, ¿øÀÎ ±ÕÀº Æó·Å ±ÕÀ̳ª ±× ¹ÛÀÇ È­³ó±ÕÀÌ´Ù. Áõ¼¼´Â º´¼ÒÀÇ Å©±â³ª ¿øÀÎ ±Õ¿¡ µû¶ó ´Ù¸£Áö¸¸, ±âħ, ¹ß¿­, ¹ßÇÑ, È£Èí °ï¶õ, Ä¡¾Æ³ëÁ¦, ÈäÅë µîÀÌ ÀÖ´Ù. X¼± »çÁøÀ¸·Î´Â °æ°è°¡ ¼±¸íÇÏÁö ¸øÇÑ ºÒ±ÔÄ¢ÀûÀÎ ÀÛÀº À½¿µÀÌ »êÀçÇÑ´Ù. ûÁøÇϸé È¯Ãø¿¡ ¼öÆ÷À½ µîÀÇ ÀâÀ½ÀÌ µé¸°´Ù. Ä¡·á´Â ¾ÕÀÇ ´ë¿±¼º Æó·Å°ú °°´Ù. ¡¼¹ÙÀÌ·¯½º¼º Æó·Å¡½ ¿ø¹ß¼º ÀÌÇü Æó·Å, ÀÎÇ÷翣ÀÚ Æó·Å, ¾Þ¹«º´¹ÙÀÌ·¯½º Æó·Å, ¾Æµ¥³ë ¹ÙÀÌ·¯½º Æó·Å µîÀÌ ÀÖ´Ù. ¿ø¹ß¼º ÀÌÇü Æó·ÅÀº °æ¹ÌÇÑ ¹ß¿­°ú ½ÉÇÑ ±âħ, °¡·¡, ÈäÅëÀÌ ÁÖ¿ä Áõ¼¼ÀÌ´Ù. X¼± »çÁø¿¡¼­´Â Æó¹®ºÎ¿¡¼­ ¸»ÃÊ·Î ÇâÇÏ´Â ¿¯Àº ±ÕÀÏÇÑ À½¿µÀÌ Æ¯Â¡À̸ç ÇÏÆó¾ß¿¡¼­ º¼ ¼ö ÀÖ´Ù. Áø´Ü¿¡´Â ÀûÇ÷±¸ ÇÑ·© ÀÀÁý ¹ÝÀÀÀ̳ª ¿¬¼â ±¸±Õ MG ÀÀÁý ¹ÝÀÀÀÌ À¯È¿ÇÏ´Ù. Ä¡·á¿¡´Â Åׯ®¶ó»çÀÌŬ¸°
  • pneumonia,in immunocompromised host
    ¸é¿ª ±â´É ÀúÇÏ ¼÷ÁÖÀÇ
  • postoperative pneumonia
    ¼ö¼úÈÄ Æó·Å, ¼úÈÄ Æó·Å
  • rheumatic pneumonia
    ·ù¸¶Æ¼½º¼º Æó·Å
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
Pittsburgh pneumonia agent A species that causes Pittsburgh pneumonia, a variant of Legionnaires' disease. Accounts for approximately 60% of Legionella pneumonias other than those caused by Legionella pneumophila.
Synonym: Pittsburgh pneumonia agent.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
Pittsburgh pneumonia A variant of Legionnaires' disease caused by Legionella micdadei.
(05 Mar 2000)
Eaton agent pneumonia An acute systemic disease with involvement of the lungs, caused by Mycoplasma pneumoniae and marked by high fever, cough, relatively few physical signs, and scattered densities on X-rays; usually associated with development of cold agglutinins and antibodies to the bacteria.
Synonym: atypical pneumonia, Eaton agent pneumonia, mycoplasmal pneumonia.
(05 Mar 2000)
adrenergic blocking agent A compound that selectively blocks or inhibits responses to sympathetic adrenergic nerve activity (sympatholytic agent) and to epinephrine, norepinephrine, and other adrenergic amines (adrenolytic agent); two distinct classes exist, alpha-and beta-adrenergic receptor blocking agent's.
(05 Mar 2000)
adrenergic neuronal blocking agent A drug that prevents the release of norepinephrine from sympathetic nerve terminals; it does not inhibit the responses of the adrenergic receptors to circulating epinephrine, norepinephrine, and other adrenergic amines.
(05 Mar 2000)
agent <pharmacology> Any power, principle or substance capable of producing an effect, whether physical, chemical or biological.
Origin: L. Agens = acting
(18 Nov 1997)
agent, antihypertensive As the name suggests, a drug aimed at reducing high blood pressure (hypertension).
(12 Dec 1998)
agent, anti-infective Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright.
(12 Dec 1998)
Agent Orange An herbicide and defoliant, consisting of (2,4,5-trichlorophenoxy)acetic acid, (2,4-dichlorophenoxy)acetic acid, and dioxin, that was widely used in the Vietnam War; it has been shown to possess residual post-exposure carcinogenic and teratogenic properties in humans.
(05 Mar 2000)
agent, tocolytic A medication that can inhibit labour, slow down or halt the contractions of the uterus. Tocolytic agents are widely used today to treat premature labour and permit pregnancy to procede and so let the foetus gain in size and maturity before being born.
(12 Dec 1998)
alkylating agent <oncology, pharmacology> A reagent that places an alkyl group, for example propyl in place of a nucleophilic group in a molecule. Alkylating reagents include a number of cytotoxic drugs some of which react fairly specifically with N7 of the purine ring and lead to depurination of DNA, for example the agent ethyl ethanesulphonic acid and thus to mutagenesis. The drugs interaction with DNAand prevents the division of the cells.
Examples of drugs include: busulphan, chlorambucil, cyclophosphamide, melphalan.
(29 Sep 1997)
alpha-adrenergic blocking agent An agent that competitively blocks alpha-adrenergic receptors; used in the treatment of hypertension.
Synonym: alpha-blocker.
(05 Mar 2000)
antianxiety agent A functional category of drugs useful in the treatment of anxiety and able to reduce anxiety at doses which do not cause excessive sedation (e.g., diazepam).
Synonym: anxiolytic, minor tranquilliser.
(05 Mar 2000)
antidiabetic agent A substance that helps a person with diabetes control the level of glucose (sugar) in the blood so that the body works as it should. See: insulin.
(09 Oct 1997)
antifibrinolytic agent Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive haemorrhage and in other coagulation disorders.
(12 Dec 1998)
antifoam agent A chemical that reduces the surface tension of foams that form on thesurface of broths in fermentors because of aeration or agitation. Stearyldecanol, octal decanol, vegetable oils, silicones, sulphonates, andpolypropylene glycol are typically used, though they can cause problems inrefining the broth later on.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pneumonia
    Æó·Å
  • double pneumonia
    (ÀÇ)¾çÃø Æó·Å
  • pneumonia
    Æó·Å
  • primary atypical pneumonia
    1Â÷¼º ºñÁ¤Çü Æó·Å
  • agent
    ´ë¸®ÀÎ
  • Eaton agent
    (ÀÇ)ÀÌÆ° ÀÎÀÚ
  • Indian agent
    (¹Ì ij³ª´Ù)Àεð¾ð °ü¸®°ü
  • ad agent
    ±¤°í ´ëÇà¾÷ÀÚ
  • agent
    ´ë¸®ÀÎ;ÁÖ¼±ÀÎ;ÇàÀ§ÀÚ;ÀÛÀÎ
  • book agent
    ¼­Àû¿ÜÆÇ¿ø
  • business agent
    ¾÷¹«´ë¸®
  • commission agent
    °Å°£²Û;Á߸ÅÀÎ;»ç¼³ ¸¶±ÇÀå¼ö
  • consular agent
    ¿µ»ç ´ë¸®
  • contact agent
    Ã˸Å;Á¢ÃËÁ¦(catalyzer)
  • conversion agent
    Àüȯ ´ë¸® ±â°ü
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á